期刊文献+

Ⅰb~Ⅱa期子宫颈癌预后分析 被引量:7

原文传递
导出
摘要 宫颈癌是当今威胁女性健康的最常见的生殖系统恶性肿瘤,每年新发病例数接近50万,死亡约27万,而且大约4/5发生在发展中国家。对于Ⅰb~Ⅱa期宫颈癌,目前的治疗方式仍然以手术为主,术后对于有高危因素的患者给予辅助治疗,总体5年生存率为54%-90%。本研究通过回顾性分析762例Ⅰb~Ⅱa期宫颈癌患者的临床病理资料,探讨影响Ⅰb~Ⅱa期宫颈癌预后的危险因素以及治疗方式对预后的影响。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2010年第3期224-226,共3页 Chinese Journal of Obstetrics and Gynecology
基金 广东省科学技术厅计划(2006835901005)
  • 相关文献

参考文献14

  • 1Landoni F,Maneo A,Colombo A,et al.Randomised study of radical surgery versus radiotherapy for stage Ⅰ b-Ⅱ a cervical cancer.Lancet,1997,350:535-540.
  • 2陈鲁,吕卫国,谢幸,陈怀增,俞华,倪型灏.子宫颈鳞癌Ⅰb~Ⅱa期患者预后预测系统的建立及其临床意义[J].中华妇产科杂志,2005,40(4):239-242. 被引量:25
  • 3Biewenga P,van der Velden J,Mol BW,et al.Validation of existing prognostic models in patients with early-stage cervical cancer.Gynecol Oncol,2009,115:277-284.
  • 4章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 5陈雅卿,郑爱文,楼洪坤.ⅠB~ⅡB期前宫颈癌髂总淋巴结转移的临床分析[J].中华肿瘤防治杂志,2007,14(14):1097-1099. 被引量:8
  • 6Aoki Y,Sasaki M,Watanabe M,et al.High-risk group in node-positive patients with stage ⅠB,ⅡA,and ⅡB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.Gynecol Oncol,2000,77:305-309.
  • 7Pras E,Willemse PH,Canrinus AA,et al.Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment Int J Radiat Oncol Biol Phys,2002,52:23-32.
  • 8Esajas MD,Duk JM,de Bruijn HW,et al.Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.J Clin Oncol,2001,19:3960-3966.
  • 9Shimada M,Kigawa J,Nishimura R,et al.Ovarian metastasis in carcinoma of the uterine cervix.Gynecol Oncol,2006,101:234-237.
  • 10Landoni F,Zanagnolo V,Lovato-Diaz L,et al.Ovarian metastases in early-stage cervical cancer (I A2-J A):a multicenter retrospective study of 1965 patients.Int J Gynecol Cancer,2007,17:623-628.

二级参考文献23

  • 1宋红林,唐步坚.放化疗联合疗法在中晚期宫颈癌治疗中的应用分析[J].肿瘤防治杂志,2004,11(6):641-642. 被引量:12
  • 2Estape RE, Angioli R, Madrigal M, et al.Close vaginal margins as a prognostic factor after radical hysterectomy. Gynecol Oncol,1998,68:229-232.
  • 3Kamura T, Tsukamoto N, Tsuruchi N, et al. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy.Cancer,1992,69:181-186.
  • 4Yuan CC, Wang PH, Lai CR, et al. Prognosis-predicting system based on factors related to survival of cervical carcinoma. Int J Gynaecol Obstet, 1998,63:163-167.
  • 5Ho CM, Chien TY, Huang SH, et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol,2004,93:458-464.
  • 6Aoki Y, Sasaki M, Watanabe M, et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol,2000,77:305-309.
  • 7Iwasaka T, Kamura T, Yokoyama M, et al. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: a comparison with effects of adjuvant radiotherapy. Obstet Gynecol,1998,91:977-981.
  • 8Curtin JP, Hoskins WJ, Venkatraman ES, et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase Ⅲ trial. Gynecol Oncol,1996,61:3-10.
  • 9Berek JS. Novak′s gynecology.13th ed. Philadelphia: Lippincott Williams & Wilkins,2002.1199-1244.
  • 10Monk B J,Cha D S,Walker J L,et al.Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage ⅠB and IA cervical carcinoma[J].Gynecol Onco1,1994,54 (1):4-9.

共引文献69

同被引文献52

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部